These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk. Provenzale D; Schmitt C; Wong JB Am J Gastroenterol; 1999 Aug; 94(8):2043-53. PubMed ID: 10445526 [TBL] [Abstract][Full Text] [Related]
24. [Prevalence of Barrett's esophagus in patients with colorectal carcinoma]. Sandoval-Arrieta MI; Alfaro-Fattel LG; Bermúdez-Ruiz H; Córdova-Charraga JA; Domínguez-Pérez EA; Ramírez-Mazariegos NE; Morales-Benítez A; Caneda-Mejía M; Aguirre-López E; Soto-Sánchez J; Alvarado I; Rendón ME Rev Gastroenterol Mex; 2001; 66(3):126-30. PubMed ID: 11917444 [TBL] [Abstract][Full Text] [Related]
25. [The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD]. Endzinas Z; Mickevicius A; Kiudelis M Zentralbl Chir; 2004 Apr; 129(2):99-103. PubMed ID: 15106039 [TBL] [Abstract][Full Text] [Related]
26. Prospective multivariate analysis of factors predictive of complete regression of Barrett's esophagus. Weston AP; Badr AS; Hassanein RS Am J Gastroenterol; 1999 Dec; 94(12):3420-6. PubMed ID: 10606297 [TBL] [Abstract][Full Text] [Related]
27. Colorectal neoplasia in veterans is associated with Barrett's esophagus but not with proton-pump inhibitor or aspirin/NSAID use. Siersema PD; Yu S; Sahbaie P; Steyerberg EW; Simpson PW; Kuipers EJ; Triadafilopoulos G Gastrointest Endosc; 2006 Apr; 63(4):581-6. PubMed ID: 16564855 [TBL] [Abstract][Full Text] [Related]
28. The prevalence of Helicobacter pylori infection and the status of gastric acid secretion in patients with Barrett's esophagus in Japan. Abe Y; Ohara S; Koike T; Sekine H; Iijima K; Kawamura M; Imatani A; Kato K; Shimosegawa T Am J Gastroenterol; 2004 Jul; 99(7):1213-21. PubMed ID: 15233656 [TBL] [Abstract][Full Text] [Related]
29. Colonic neoplasia in asymptomatic persons with negative fecal occult blood tests: influence of age, gender, and family history. Rex DK; Lehman GA; Ulbright TM; Smith JJ; Pound DC; Hawes RH; Helper DJ; Wiersema MJ; Langefeld CD; Li W Am J Gastroenterol; 1993 Jun; 88(6):825-31. PubMed ID: 8503374 [TBL] [Abstract][Full Text] [Related]
30. The prevalence of intestinal metaplasia in patients with and without peptic strictures. Kim SL; Wo JM; Hunter JG; Davis LP; Waring JP Am J Gastroenterol; 1998 Jan; 93(1):53-5. PubMed ID: 9448174 [TBL] [Abstract][Full Text] [Related]
31. Prevalence and malignant potential of colorectal polyps in asymptomatic, average-risk men. DiSario JA; Foutch PG; Mai HD; Pardy K; Manne RK Am J Gastroenterol; 1991 Aug; 86(8):941-5. PubMed ID: 1858757 [TBL] [Abstract][Full Text] [Related]
37. [Association between symptomatic gastroesophageal reflux and Barrett's esophagus]. Trujillo-Benavides OE; Baltazar-Montúfar P; Angeles-Garay U; Ramírez-Mendoza P; Navarro-García AM; Paredes-Cruz E; Méndez del Monte R; Guerrero-Hernández M Rev Gastroenterol Mex; 2005; 70(1):14-9. PubMed ID: 16170957 [TBL] [Abstract][Full Text] [Related]
38. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma. Weston AP; Badr AS; Hassanein RS Am J Gastroenterol; 1999 Dec; 94(12):3413-9. PubMed ID: 10606296 [TBL] [Abstract][Full Text] [Related]
39. Relationship between rate of change in acid exposure along the esophagus and length of Barrett's epithelium. Tharalson EF; Martinez SD; Garewal HS; Sampliner RE; Cui H; Pulliam G; Fass R Am J Gastroenterol; 2002 Apr; 97(4):851-6. PubMed ID: 12003418 [TBL] [Abstract][Full Text] [Related]
40. The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus. Katz D; Rothstein R; Schned A; Dunn J; Seaver K; Antonioli D Am J Gastroenterol; 1998 Apr; 93(4):536-41. PubMed ID: 9576444 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]